Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus

Although nucleot(s)ide analogues and pegylated interferon alpha 2a (PEG-IFN-α2a) can suppress hepatitis B virus (HBV) replication, it is difficult to achieve complete HBV elimination from hepatocytes. A novel site-specific pegylated recombinant human IFN-β (TRK-560) was recently developed. In the pr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Tsuge, Masataka, Uchida, Takuro, Hiraga, Nobuhiko, Kan, Hiromi, Makokha, Grace Naswa, Abe-Chayama, Hiromi, Miki, Daiki, Imamura, Michio, Ochi, Hidenori, Hayes, C. Nelson, Shimozono, Rieko, Iwamura, Tomokatsu, Narumi, Hideki, Suzuki, Tomohiko, Kainoh, Mie, Taniguchi, Tadatsugu, Chayama, Kazuaki
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2017
Teme:
Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444133/
https://ncbi.nlm.nih.gov/pubmed/28373196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00183-17
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki